GL1X · GenesisL1 explorer

Research workbench

Selectivity switch between fak and PYK2: macrocyclization of fak inhibitors improves PYK2 potency

Analyse Selectivity switch between fak and PYK2: macrocyclization of fak inhibitors… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5TOB
Type
protein
Length
245 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine kinase 2-beta
EC
2.7.10.2
UniProt
Q14289
Ligands
YAM
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine kinase 2-beta (EC 2.7.10.2)protein24545% helix, 18% strandQ14289

Ligands and binding sites

  • YAM · N-methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-5-yl) amino]-5-(trifluoromethyl)pyrimidin-4-yl}amino) methyl]pyridin-2-yl}methanesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13140.630.7940YAM

Compared structures

  • 5TOB · Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q14289 · AlphaFold monomer V2.0 prediction for protein-tyrosine kinase 2-beta (Q14289) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.